AAD 2020: Investigational Lebrikizumab Improves Atopic Dermatitis in Phase IIb Trial
The drug has already moved onto phase III testing
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
The drug has already moved onto phase III testing
Only registered members have full access to PracticeUpdate content.